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1. Introduction 
Autism spectrum disorder (ASD) or pervasive developmental disorder (PDD) is a 
neurodevelopmental disease, beginning in childhood but extending through to adulthood. 
ASD is characterised by impairments in reciprocal social interaction and communication, 
and by restricted or stereotyped patterns of interests and activities. This disorder has 
received much scientific and social attention1,2. ASD is more common than previously 
supposed with a frequency of 0.6-3 out of 100 births2-6 and occurs either sporadically or in a 
familial pattern, and far more commonly in males7-9. The etiology remains largely 
unknown10. Previously we demonstrated that CD38 acts as a ‘niceness’ protein for mouse 
social behavior, by regulating release of oxytocin (OT)11, which seems to be essential for 
mutual recognition and trust12,13. Therefore, here, we describe our results on single 
nucleotide polymorphisms (SNPs) of CD38 in ASD patients and control subjects14. In 
addition, we report our experience of treatment of one ASD patient with a CD38 SNP by 
nasal OT administration. 
2. Results 
Figures 1 and 2 show human CD38 expression in the frontal cortex, cerebellum, 
hypothalamus and amygdala, by RT-PCR with human brain RNA samples which were used 
for synthesizing cDNAs. CD38 mRNA was highly expressed in the hypothalamus in the 
human brain, suggesting that CD38 has an important role on human social behavior, as in 
the mouse11.  
Armed with this new information about CD38 in the human brain, we set out to examine 
the human CD38 gene. The mRNA for CD38 is transcribed from human chromosome 
4p1515,16. The CD38 gene consists of 8 exons, spanning a genomic stretch of 70.51 kb (mRNA: 
1227 bases)  (http://www.broad.mit.edu/mpg/haploview; Figure 3a). SNP screening in 8 











Fig. 1. Semi-quantitative RT-PCR confesses human CD38 expression in the frontal cortex 
(F. Cort), the cerebellum (Cbl), the hypothalamus (Hyp) and the amygdala (Amyg). 
Human brain RNA samples provided commercially (Ambion) were used for synthesizing 
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Fig. 2. mRNA expression levels of CD38 gene in various human brain tssues. (a) The 
relatve expression level of human CD38 gene was determined in RNA samples from frontal 
cortex, cerebellum, hypothalamus and amygdala using real‐tme quantitatve PCR. 
Housekeeping normalized units (threshold cycle) for each gene obtained in the PCR analysis 
were used to determine the fold‐change among samples. Bars represent fold‐changes of the 
mRNA level of CD38 when comparing cerebellum with other tssues. Data are expressed as 
the mean  S.D., performed in duplicate and repeated 3 times. *p<0.01, **p<0.01, 
Significantly increased from cerebellum value (P<0.01 and P<0.001). (b) Each plot represents 
the baseline‐subtracted fluorescence intensity (ΔRn) that reflects mRNA levels of CD38 or 
β‐actin genes. Horizontal lines indicate threshold lines set in the exponentially increasing 
area calculated by using SDS software. 
subjects (the sample set A in Table 1) fulfilling Diagnostic and Statistical Manual of Mental 
Disorders, 4th edition (DSM-IV, American Psychiatric Association, 1994), criteria for ASD, 
and in 201 non-clinical control subjects (sample set E), in the Kanazawa area in Japan. We 
detected 12 SNPs that had already been reported, plus 3 novel mutations (Figure 3a). Allelic 
and genotypic frequencies in these samples are summarized in Tables 2 and 3. Among them, 
as shown in Figure 3b, we detected the C4693T mutation in exon 3 (SNP13; rs1800561) that 
leads to an arginine (R)-to-tryptophan (W) substitution at amino acid 140, R140W.  
In the following experiments, we focused mainly on this mutation, because of functional 
abnormality in R140W-substituted-CD38: (1) The R140 is relatively well conserved among 
multiple species except for the rodent (Figure 3c). R140 is located in the flexible loop (137-
141) at the midpoint of the N- and C-ternimus domains between two helical domains (a4 
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Fig. 3. Genome and molecular structures and mutations of CD38. 
(a) Genomic structure of CD38 and locations of SNPs in introns (upper) and in exons 
(lower). Exons are indicated by boxes, with translated regions in closed boxes, and 
untranslated regions in open boxes. Mutations at amino acids at positions of 47, 116, 140, 168 
and 264 of CD38 are indicated. Numbering of the nucleotides starts at the A of ATG 
encoding the initial methionine and refers to Genbank accession number D84284. 
(b) Sequence trace was derived from a blood DNA sample of 4693C/T heterozygote.  
(c) Conservation of R at the 140th amino acid among different species, except for the rodent. 
Sequences were obtained through the accession numbers of NM001775, AY555148, 
NM175798, AF117714, AF272974, NM013127, NM007646, D30048, and M85206/M37644 for 
the indicated species, respectively. It is noted that mutant structure has more open-form 
conformation than wild-type and its variation is slightly larger.  
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and a5) and is the pivot of the hinge region connecting two regions of L-shaped molecule17. 
Therefore, the mutation (W140) causes severe perturbations of the predicted protein 
structure, if compared with the human (R140), rabbit (K140) or mouse (G140) CD38 (see 
Figure 7 in ref.14). (2) Indeed, the mutant W140-CD38 showed one third of ADP-ribosyl 
cyclase activity of wild-type CD38 expressed in the CHO cells15. (3) Social amnesia was not 














A 29 (23/6) 12 to 44 22.8+/-7.6 Unrelated ASD Japan* 0.052 
B 3 (3/0) 21 to 44 30.0+/- 7.1 3 probands in A Japan* 1 
C 25 (15/10) 21 to 84 53.0+/-4.6 3 families in B Japan* 0.32 
D 252 (252/0) ASD USA** 0 20, 21 
E 201 (106/95) 22 to 64 32.5+/-0.9 Unscreened control Japan* 0.007 
*In the Kanazawa area **AGRE samples




N Allele counts Frquency N Allele counts Frequency 
SNP01 rs3796878 G>A 400 4 0.01 58 0 0 
SNP02 rs3796875 A>G 398 100 0.25 56 18 0.321 
SNP03 rs6449197 C>T 392 81 0.207 58 16 0.275 
SNP04 rs11574927 A>G 402 78 0.195 58 6 0.103 
SNP05 rs10805347 A>G 400 180 0.452 58 22 0.379 
SNP06 rs3796863 C>A 398 148 0.371 58 20 0.345 
SNP07 rs1130169 C>T 398 36 0.341 56 15 0.268 
SNP08 rs13137313 A>G 398 176 0.442 58 28 0.483 
SNP09 rs17476066 T>C 392 46 0.117 58 6 0.103 
SNP10 rs3733593 C>T 398 128 0.32 56 17 0.305 
SNP11 C>G 402 1 0.002 58 0 0 
SNP12 C>T 402 0 0 58 1 0.017 
SNP13 rs1800561 C>T 402 3 0.008 58 3 0.052 
SNP14 rs1800051 A>C 402 59 0.146 58 13 0.22 
SNP15 C>T 402 6 0.015 58 0 0 
*SNPs are denoted as major allele>minor allele 
Table 2. Alleleic frequency of SNPs in control and ASD subjects 
The 140R/W (C4693T) heterozygotes were found in 3 male subjects (sample set B; two 
autistic and one Asperger) out of 29 ASD patients examined (23 males and 6 females with 
the mean age = 22.8  7.6; prevalence of 10.3% of ASD samples). We examined whether or 
not the W140 allele seems to be co-segregated with ASD and ASD-related traits in 3 
probands’ families. Twenty five members of the 3 kindred families (sample set C) were 
available for detailed clinical and genetic analyses (Figure 4). The 4693C-to-T change was 
found in all probands’ fathers in the 3 families and brothers in the 2 families (Family #1 and 
#3). The mutation is present in the grandmother of the father’s side in the Family #1 (1-I-4) 




Autism – A Neurodevelopmental Journey from Genes to Behaviour 188 
 
Fig. 4. Pedigrees for three families of ASD probands carrying the W140. Affected males 
(probands) are indicated with red arrows. Affected or carrier males or females are indicated 
by filled squares or circles, respectively. Empty symbols denote individuals with no 
mutation. Gray symbols indicate undetermined with no DNA available for analysis. Sexes 
are hidden by diamond symbols upon request. The subjects are indicated by progressive 
Arabic numbers according to the three generations. The current study was approved by the 
ethical committee of Kanazawa University Graduate School of Medicine. Subjects marked 
with symbols are: **, denotes ASD; *, ASD traits; P, PDD-NOS; A, Asperger disorder.  
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Fig. 5. Expression of the minor allele of rs1800561 
(A) cDNA with 4693C has MspAII site. (B) RT-PCR products from blood RNA samples were 
digested by MspAII. An RT-PCT product from a homozygous 4693C/C subject gives two 
bands, while a heterozygous 4693C/T subject giving three bands. (C) Sequencing of RT-PCR 
products confirms the SNP.  
www.intechopen.com
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Family #3 (3-I-3), in an apparently autosomal dominant fashion. We found a total of 18 
carriers in 28 family members cooperative (prevalence=64%). In all cases the mutation was 
heterozygous (allelic frequency=0.32). The mutant allele was indeed transcribed in the 
subjects tested (Figure 5).  
The kindred were clinically evaluated by interviewing. The probands’ young (1-III-2 in the 
Family #1) and old (3-III-1 in the family #3) brothers showed clinical features conforming to 
PDD-NOS (PDD not otherwise specified) or Asperger. Two fathers (1-II-2 and 3-II-1) in their 
50s and another father (2-I-1) in his 70s were all diagnosed as having with ASD traits.  Most 
other adults over 50 years old in these pedigrees had not been clinically diagnosed with 
ASD or other psychiatric diseases, though some showed personal traits such as eccentricity, 
resulting in 8 ASD subjects out of 13 male carriers (62%). Interestingly, four young female 
cousins with (1-III-3 and 1-III-4 in the family #1) and without (3-III-3 and 3-III-4 in the 
family #3) the mutation, had no clinical ASD phenotype. 
We also evaluated them from the score of the Autism-Spectrum Quotient (AQ)18,19, in which 
older subjects esteemed themselve by recalling behaviours at their life period of 20s. AQ 
scores in two young male carriers in the family #1 (1-III-1 and -2) fulfilled the criteria (cut-
off point of 28) of ASD, though this score was not obtained from two other ASD probands 
(in the families #2 and #3), because of low intelligence (Figure 6). Some carriers’ scores were 
above the standard deviation of average values in noncarrier family members who showed 
normal control scores, indicating that such carriers may be considered to manifest ASD 
traits, even though not affected at the clinical level (Figure 6a). Statistically there is no 
difference between three different age groups (young, middle and old generations), but the 
males’ score was significantly higher than that of females (p<0.05; Figure 6b). These clinical 
and self-describing evaluations suggest that this gene polymorphism is important to 
determine the ASD or ASD trait phenotype. 
Given these results, we obtained serum samples from the kindreds to further study the 
connection between the human CD38 mutation and plasma OT or arginine vasopressin (AVP) 
levels, since we previously showed that a null mutation of Cd38 resulted in the selective 
decrease of plasma OT levels in mice11, and low levels of OT have been reported in autistic 
children20. The plasma OT levels in the carriers (161.3  26.5 pg/ml, n=12) were lower than 
those of kindred non-carriers (345.8  61.3 pg/ml, n=10; p<0.01), as shown in Figure 7. The 
differences seem to be found in the younger generation but not so in older subjects (Figure 7c). 
The OT levels of three probands and two young carriers were compared with ASD patients 
without the W140 mutation (in the sample set A): the levels of five W140 carriers (79.2  16.6 
pg/ml; n=5) were lower than those without the mutation (147.7  15.0 pg/ml; p<0.01, n=26). 
Furthermore, the OT level of the carrier ASD probands was significantly lower when 
compared with that in 101 adult control (198.2  24.7 pg/ml; p<0.01). As expected, there is no 
difference in AVP levels between CD38-mutation-carriers and –noncarriers in the pedigrees 
(Figure 7b and d). Low plasma hormone levels were frequently observed in subjects with high 
AQ scores in carriers in the pedigrees (Figure 7e and f).  
We also analysed the R140W mutation in 252 ASD subjects (excluding Hispanic and Asian 
peoples) recruited to the Autism Genetic Resource Exchange (AGRE; http://www.agre.org)21 
in USA (sample set D22). No mutation was found, suggesting ethnicity-dependent frequency 
differences. Finally, from 201 healthy unscreened control subjects (sample set E), 2 females and 
1 male were positive for the mutation, representing allelic frequency of 0.007 (Tables 2 and 3). 
This frequency is 7.4-fold lower than those (0.052) in ASD patient group in the same residential 
area (p<0.028; Table 3). 
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Fig. 6. AQ score in family members in the three pedigrees.  (a) Assessment groups were: 
W140: n=14 family members with the monoallelic R140W mutation; R140: n=7 persons 
without the mutation in the families. Horizontal dashed bar indicates the critical score of 28 
obtained from clinical ASD group in a separate experiment18. The mean and standard 
deviation range of AQ scores were illustrated.  Note that 5 individuals show the 
intermediate score above the control range but below the ASD score. The score with R140W 
is higher than that without (one-way ANOVA, p<0.05). (b) A plot of AQ scores of each 
individual of family members with or without the R140W mutation according to age. No 
significance was found between three generations (20<age<40, 40<age<60 and 60<age) by 
two-way ANOVA. The scores of males are significantly higher than those of females 
(p<0.05). Circles indicate female, and squares, male. 
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Fig. 7. Plasma oxytocin and vasopressin levels in family members. Plasma concentrations 
of OT (a) and AVP (b) levels in family members with (W140; n=12, red or orange bar) or 
without (R140; n=10, green or blue bar) heterozygous R140W allele. Mean  s.e.m. **, p<0.01 
(one-way ANOVA). OT (c) or AVP (d) levels in the three kindred according to age. OT (e) or 
AVP (f) levels as a function of AQ scores. Red and orange symbols or green and blue 
symbols indicate levels from persons with or without the R140W mutation, respectively. 
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P-value from Fisher’s exact test. SNPs11, 14 and 15 were not analysed. 
Table 3. Statistical analysis of SNPs in 29 ASD and 201 control subjects in the Kanazawa 
area 
One proband receiving intranasal OT for 6 months showed improvements in the area of social 
approach, eye-contact and communication behavior without serious adverse effects. These 
results suggest that the CD38 W140 allele could be a possible risk factor for one form of ASD 
by abrogating OT function and the carriers become candidates for the OT treatment14. 
3. Discussion 
ASD is heterogeneous and forms a continuum, and thus is likely to involve many genes7-
10,23-26. De novo mutations related to ASD are rarely inherited7, but some ASD also can be 
inherited from pre-existing genetic variants in parents, for both of which a unified 
mechanism was proposed9. Our results shed light on genetic mutations of CD38 in relatively 
mature ASD patients and the inheritable ASD subgroups of three independent families in 
which the CD38-R140W mutation showed relative co-segregation with diverse phenotypes 
of ASD. In such multiplex families, the risk of autism or ASD traits in young male offsprings 
is nearly ~100%, representing dominant transmission of a mutation with high penetrance. 
However, we cannot completely exclude as yet unidentified contributing factors.  
The heterozygous 4693C/T carriers were identified in Japanese and Italian general 
populations16,27. The presence of this mutation in Japanese has already been reported in the 
HapMap site (http://www.hapmap.org/) and by Yagui et al. in 199815. Surprisingly, the 
carriers were also identified in females. Therefore, it is highly possible that even clinically-
unaffected female carriers with this mutant allele could in turn transmit the mutation to 
their offspring with high penetrance in males. Currently, we are intensively collecting blood 
samples for mutation analysis from many ASD and control subjects in different cities and 
countries to support our finding, which so far has been carried out in a relatively small 
group in a restricted area.  
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A noteworthy role for OT in social recognition has been shown in rodent and human 
studies12,13. Recently, a 1.1-Mb deletion of 20p13 including the OT gene (copy number 
decrease) has been detected in a child with Asperger disorder8. An association of one or two 
intronic SNPs in the OT receptor gene with autism has also been reported25,28,29, suggesting 
that defects in OT signaling confer genetic vulnerability to ASD. Though the R140W 
mutation was not found in 252 American AGRE samples, the association study with 
tagSNPs showed one SNP (SNP06; rs3796863) that is positively related (p<0.004) with 
American high functioning autism14.  
In conclusion, CD38 mutations provide one genetic basis for those instances of ASD that 
arises from disruption of the OT signaling. Thus, our finding provides the first theoretical 
background for the evidence-based treatment by OT infusion for a subgroup of ASD 
patients with the lower plasma OT level14, which has already been tried for non-selected 
ASD subjects30,31. 
4. Methods summary  
Clinical and genetic studies were carried out according to institutional guidelines after 
ethical approval of participating institutions and informed consent was obtained from all 
participating patients. A total of 29 unrelated affected individuals out of 96 in the Kanazawa 
area in Japan (Sample set A) were admitted the Kanazawa University Hospital diagnosed 
with DSM-IV in accordance with clinical criteria. Blood and platelet biochemical analyses 
were performed in 29 ASD probands and their parents and family members who agreed to 
supply. Genotyping for the association study and mutation screening were performed by 
direct sequencing or TaqMan technology. PCR products were sequenced with the BigDye 
Terminator Cycle Sequencing Kit (V3.1, Applied Biosystems, Foster City, CA, USA). 
Samples were then subjected to electrophoresis, using an ABI PRISM genetic analyzer 
(Applied Biosystems). Absence of genotyping errors was controlled by sequencing the PCR 
product with the opposite primer in a subset of patients.  
Statistics: Data are expressed as mean  s.d. or s.e.m. Statistical analysis was performed 
using one-way or two-way ANOVA. The criterion for significance in all cases was p<0.05. 
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